nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Doxorubicin—stomach cancer	0.151	0.442	CbGbCtD
Bosentan—CYP2C9—Capecitabine—stomach cancer	0.079	0.231	CbGbCtD
Bosentan—CYP2C9—Fluorouracil—stomach cancer	0.0469	0.137	CbGbCtD
Bosentan—ABCB11—bile—stomach cancer	0.0343	0.515	CbGeAlD
Bosentan—CYP3A4—Irinotecan—stomach cancer	0.0284	0.0831	CbGbCtD
Bosentan—CYP3A4—Docetaxel—stomach cancer	0.0208	0.0609	CbGbCtD
Bosentan—CYP3A4—Doxorubicin—stomach cancer	0.0155	0.0454	CbGbCtD
Bosentan—EDNRB—pancreas—stomach cancer	0.00543	0.0815	CbGeAlD
Bosentan—ABCB11—digestive system—stomach cancer	0.00374	0.0562	CbGeAlD
Bosentan—EDNRB—liver—stomach cancer	0.00345	0.0519	CbGeAlD
Bosentan—ABCB11—endocrine gland—stomach cancer	0.00309	0.0465	CbGeAlD
Bosentan—ABCB11—liver—stomach cancer	0.00279	0.0419	CbGeAlD
Bosentan—EDNRB—lymph node—stomach cancer	0.00265	0.0398	CbGeAlD
Bosentan—EDNRA—lymph node—stomach cancer	0.00219	0.0329	CbGeAlD
Bosentan—CYP2C9—hematopoietic system—stomach cancer	0.00182	0.0274	CbGeAlD
Bosentan—CYP3A4—hematopoietic system—stomach cancer	0.00139	0.0209	CbGeAlD
Bosentan—CYP2C9—digestive system—stomach cancer	0.00127	0.019	CbGeAlD
Bosentan—CYP2C9—endocrine gland—stomach cancer	0.00105	0.0157	CbGeAlD
Bosentan—CYP3A4—digestive system—stomach cancer	0.000967	0.0145	CbGeAlD
Bosentan—CYP2C9—liver—stomach cancer	0.000945	0.0142	CbGeAlD
Bosentan—CYP3A4—endocrine gland—stomach cancer	0.000799	0.012	CbGeAlD
Bosentan—CYP3A4—liver—stomach cancer	0.00072	0.0108	CbGeAlD
Bosentan—Epistaxis—Doxorubicin—stomach cancer	0.000241	0.000578	CcSEcCtD
Bosentan—Anorexia—Capecitabine—stomach cancer	0.000241	0.000578	CcSEcCtD
Bosentan—Angiopathy—Methotrexate—stomach cancer	0.00024	0.000577	CcSEcCtD
Bosentan—Vomiting—Irinotecan—stomach cancer	0.00024	0.000576	CcSEcCtD
Bosentan—Sinusitis—Doxorubicin—stomach cancer	0.000239	0.000575	CcSEcCtD
Bosentan—Immune system disorder—Methotrexate—stomach cancer	0.000239	0.000574	CcSEcCtD
Bosentan—Dizziness—Fluorouracil—stomach cancer	0.000239	0.000574	CcSEcCtD
Bosentan—Mediastinal disorder—Methotrexate—stomach cancer	0.000239	0.000573	CcSEcCtD
Bosentan—Rash—Irinotecan—stomach cancer	0.000238	0.000571	CcSEcCtD
Bosentan—Dermatitis—Irinotecan—stomach cancer	0.000238	0.000571	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000238	0.000571	CcSEcCtD
Bosentan—Chills—Methotrexate—stomach cancer	0.000237	0.00057	CcSEcCtD
Bosentan—Headache—Irinotecan—stomach cancer	0.000236	0.000568	CcSEcCtD
Bosentan—Hypotension—Capecitabine—stomach cancer	0.000236	0.000567	CcSEcCtD
Bosentan—Insomnia—Docetaxel—stomach cancer	0.000236	0.000567	CcSEcCtD
Bosentan—Paraesthesia—Docetaxel—stomach cancer	0.000234	0.000562	CcSEcCtD
Bosentan—Erythema multiforme—Epirubicin—stomach cancer	0.000234	0.000562	CcSEcCtD
Bosentan—Bradycardia—Doxorubicin—stomach cancer	0.000233	0.00056	CcSEcCtD
Bosentan—Dyspnoea—Docetaxel—stomach cancer	0.000233	0.000558	CcSEcCtD
Bosentan—Somnolence—Docetaxel—stomach cancer	0.000232	0.000557	CcSEcCtD
Bosentan—Mental disorder—Methotrexate—stomach cancer	0.000232	0.000557	CcSEcCtD
Bosentan—Eye disorder—Epirubicin—stomach cancer	0.000231	0.000556	CcSEcCtD
Bosentan—Tinnitus—Epirubicin—stomach cancer	0.000231	0.000554	CcSEcCtD
Bosentan—Malnutrition—Methotrexate—stomach cancer	0.00023	0.000553	CcSEcCtD
Bosentan—Erythema—Methotrexate—stomach cancer	0.00023	0.000553	CcSEcCtD
Bosentan—Haemoglobin—Doxorubicin—stomach cancer	0.00023	0.000553	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00023	0.000553	CcSEcCtD
Bosentan—Cardiac disorder—Epirubicin—stomach cancer	0.00023	0.000552	CcSEcCtD
Bosentan—Flushing—Epirubicin—stomach cancer	0.00023	0.000552	CcSEcCtD
Bosentan—Vomiting—Fluorouracil—stomach cancer	0.00023	0.000552	CcSEcCtD
Bosentan—Dyspepsia—Docetaxel—stomach cancer	0.00023	0.000551	CcSEcCtD
Bosentan—Haemorrhage—Doxorubicin—stomach cancer	0.000229	0.00055	CcSEcCtD
Bosentan—Hepatitis—Doxorubicin—stomach cancer	0.000229	0.00055	CcSEcCtD
Bosentan—Insomnia—Capecitabine—stomach cancer	0.000228	0.000549	CcSEcCtD
Bosentan—Hypoaesthesia—Doxorubicin—stomach cancer	0.000228	0.000547	CcSEcCtD
Bosentan—Rash—Fluorouracil—stomach cancer	0.000228	0.000547	CcSEcCtD
Bosentan—Dermatitis—Fluorouracil—stomach cancer	0.000228	0.000547	CcSEcCtD
Bosentan—Paraesthesia—Capecitabine—stomach cancer	0.000227	0.000545	CcSEcCtD
Bosentan—Decreased appetite—Docetaxel—stomach cancer	0.000227	0.000545	CcSEcCtD
Bosentan—Headache—Fluorouracil—stomach cancer	0.000226	0.000544	CcSEcCtD
Bosentan—Urinary tract disorder—Doxorubicin—stomach cancer	0.000226	0.000543	CcSEcCtD
Bosentan—Oedema peripheral—Doxorubicin—stomach cancer	0.000226	0.000542	CcSEcCtD
Bosentan—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000225	0.000541	CcSEcCtD
Bosentan—Dyspnoea—Capecitabine—stomach cancer	0.000225	0.000541	CcSEcCtD
Bosentan—Fatigue—Docetaxel—stomach cancer	0.000225	0.00054	CcSEcCtD
Bosentan—Angiopathy—Epirubicin—stomach cancer	0.000225	0.00054	CcSEcCtD
Bosentan—Urethral disorder—Doxorubicin—stomach cancer	0.000225	0.000539	CcSEcCtD
Bosentan—Nausea—Irinotecan—stomach cancer	0.000224	0.000538	CcSEcCtD
Bosentan—Immune system disorder—Epirubicin—stomach cancer	0.000224	0.000537	CcSEcCtD
Bosentan—Mediastinal disorder—Epirubicin—stomach cancer	0.000223	0.000536	CcSEcCtD
Bosentan—Pain—Docetaxel—stomach cancer	0.000223	0.000536	CcSEcCtD
Bosentan—Constipation—Docetaxel—stomach cancer	0.000223	0.000536	CcSEcCtD
Bosentan—Back pain—Methotrexate—stomach cancer	0.000223	0.000535	CcSEcCtD
Bosentan—Dyspepsia—Capecitabine—stomach cancer	0.000222	0.000534	CcSEcCtD
Bosentan—Chills—Epirubicin—stomach cancer	0.000222	0.000534	CcSEcCtD
Bosentan—Decreased appetite—Capecitabine—stomach cancer	0.00022	0.000527	CcSEcCtD
Bosentan—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000218	0.000524	CcSEcCtD
Bosentan—Fatigue—Capecitabine—stomach cancer	0.000218	0.000523	CcSEcCtD
Bosentan—Vision blurred—Methotrexate—stomach cancer	0.000217	0.000521	CcSEcCtD
Bosentan—Mental disorder—Epirubicin—stomach cancer	0.000217	0.000521	CcSEcCtD
Bosentan—Erythema multiforme—Doxorubicin—stomach cancer	0.000217	0.00052	CcSEcCtD
Bosentan—Pain—Capecitabine—stomach cancer	0.000216	0.000519	CcSEcCtD
Bosentan—Constipation—Capecitabine—stomach cancer	0.000216	0.000519	CcSEcCtD
Bosentan—Erythema—Epirubicin—stomach cancer	0.000216	0.000518	CcSEcCtD
Bosentan—Malnutrition—Epirubicin—stomach cancer	0.000216	0.000518	CcSEcCtD
Bosentan—Nausea—Fluorouracil—stomach cancer	0.000215	0.000516	CcSEcCtD
Bosentan—Eye disorder—Doxorubicin—stomach cancer	0.000214	0.000514	CcSEcCtD
Bosentan—Tinnitus—Doxorubicin—stomach cancer	0.000214	0.000513	CcSEcCtD
Bosentan—Gastrointestinal pain—Docetaxel—stomach cancer	0.000213	0.000512	CcSEcCtD
Bosentan—Anaemia—Methotrexate—stomach cancer	0.000213	0.000511	CcSEcCtD
Bosentan—Cardiac disorder—Doxorubicin—stomach cancer	0.000213	0.000511	CcSEcCtD
Bosentan—Flushing—Doxorubicin—stomach cancer	0.000213	0.000511	CcSEcCtD
Bosentan—Flatulence—Epirubicin—stomach cancer	0.000212	0.00051	CcSEcCtD
Bosentan—Back pain—Epirubicin—stomach cancer	0.000209	0.000501	CcSEcCtD
Bosentan—Angiopathy—Doxorubicin—stomach cancer	0.000208	0.000499	CcSEcCtD
Bosentan—Muscle spasms—Epirubicin—stomach cancer	0.000207	0.000498	CcSEcCtD
Bosentan—Immune system disorder—Doxorubicin—stomach cancer	0.000207	0.000497	CcSEcCtD
Bosentan—Vertigo—Methotrexate—stomach cancer	0.000207	0.000497	CcSEcCtD
Bosentan—Gastrointestinal pain—Capecitabine—stomach cancer	0.000207	0.000496	CcSEcCtD
Bosentan—Mediastinal disorder—Doxorubicin—stomach cancer	0.000207	0.000496	CcSEcCtD
Bosentan—Abdominal pain—Docetaxel—stomach cancer	0.000206	0.000495	CcSEcCtD
Bosentan—Body temperature increased—Docetaxel—stomach cancer	0.000206	0.000495	CcSEcCtD
Bosentan—Leukopenia—Methotrexate—stomach cancer	0.000206	0.000495	CcSEcCtD
Bosentan—Chills—Doxorubicin—stomach cancer	0.000206	0.000494	CcSEcCtD
Bosentan—Vision blurred—Epirubicin—stomach cancer	0.000203	0.000488	CcSEcCtD
Bosentan—Cough—Methotrexate—stomach cancer	0.000201	0.000483	CcSEcCtD
Bosentan—Mental disorder—Doxorubicin—stomach cancer	0.000201	0.000482	CcSEcCtD
Bosentan—Urticaria—Capecitabine—stomach cancer	0.000201	0.000482	CcSEcCtD
Bosentan—Body temperature increased—Capecitabine—stomach cancer	0.0002	0.000479	CcSEcCtD
Bosentan—Abdominal pain—Capecitabine—stomach cancer	0.0002	0.000479	CcSEcCtD
Bosentan—Erythema—Doxorubicin—stomach cancer	0.000199	0.000479	CcSEcCtD
Bosentan—Malnutrition—Doxorubicin—stomach cancer	0.000199	0.000479	CcSEcCtD
Bosentan—Anaemia—Epirubicin—stomach cancer	0.000199	0.000478	CcSEcCtD
Bosentan—Flatulence—Doxorubicin—stomach cancer	0.000197	0.000472	CcSEcCtD
Bosentan—Arthralgia—Methotrexate—stomach cancer	0.000196	0.000471	CcSEcCtD
Bosentan—Chest pain—Methotrexate—stomach cancer	0.000196	0.000471	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000195	0.000468	CcSEcCtD
Bosentan—Discomfort—Methotrexate—stomach cancer	0.000194	0.000465	CcSEcCtD
Bosentan—Vertigo—Epirubicin—stomach cancer	0.000194	0.000465	CcSEcCtD
Bosentan—Syncope—Epirubicin—stomach cancer	0.000193	0.000464	CcSEcCtD
Bosentan—Leukopenia—Epirubicin—stomach cancer	0.000193	0.000463	CcSEcCtD
Bosentan—Back pain—Doxorubicin—stomach cancer	0.000193	0.000463	CcSEcCtD
Bosentan—Hypersensitivity—Docetaxel—stomach cancer	0.000192	0.000462	CcSEcCtD
Bosentan—Muscle spasms—Doxorubicin—stomach cancer	0.000192	0.000461	CcSEcCtD
Bosentan—Palpitations—Epirubicin—stomach cancer	0.000191	0.000457	CcSEcCtD
Bosentan—Loss of consciousness—Epirubicin—stomach cancer	0.000189	0.000455	CcSEcCtD
Bosentan—Cough—Epirubicin—stomach cancer	0.000188	0.000452	CcSEcCtD
Bosentan—Anaphylactic shock—Methotrexate—stomach cancer	0.000188	0.000451	CcSEcCtD
Bosentan—Vision blurred—Doxorubicin—stomach cancer	0.000188	0.000451	CcSEcCtD
Bosentan—Asthenia—Docetaxel—stomach cancer	0.000187	0.000449	CcSEcCtD
Bosentan—Infection—Methotrexate—stomach cancer	0.000187	0.000449	CcSEcCtD
Bosentan—Hypersensitivity—Capecitabine—stomach cancer	0.000186	0.000447	CcSEcCtD
Bosentan—Pruritus—Docetaxel—stomach cancer	0.000185	0.000443	CcSEcCtD
Bosentan—Nervous system disorder—Methotrexate—stomach cancer	0.000184	0.000443	CcSEcCtD
Bosentan—Anaemia—Doxorubicin—stomach cancer	0.000184	0.000443	CcSEcCtD
Bosentan—Thrombocytopenia—Methotrexate—stomach cancer	0.000184	0.000442	CcSEcCtD
Bosentan—Chest pain—Epirubicin—stomach cancer	0.000184	0.000441	CcSEcCtD
Bosentan—Arthralgia—Epirubicin—stomach cancer	0.000184	0.000441	CcSEcCtD
Bosentan—Anxiety—Epirubicin—stomach cancer	0.000183	0.000439	CcSEcCtD
Bosentan—Skin disorder—Methotrexate—stomach cancer	0.000183	0.000439	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000182	0.000438	CcSEcCtD
Bosentan—Hyperhidrosis—Methotrexate—stomach cancer	0.000182	0.000436	CcSEcCtD
Bosentan—Discomfort—Epirubicin—stomach cancer	0.000181	0.000435	CcSEcCtD
Bosentan—Asthenia—Capecitabine—stomach cancer	0.000181	0.000435	CcSEcCtD
Bosentan—Dry mouth—Epirubicin—stomach cancer	0.00018	0.000431	CcSEcCtD
Bosentan—Vertigo—Doxorubicin—stomach cancer	0.000179	0.00043	CcSEcCtD
Bosentan—Anorexia—Methotrexate—stomach cancer	0.000179	0.00043	CcSEcCtD
Bosentan—Syncope—Doxorubicin—stomach cancer	0.000179	0.00043	CcSEcCtD
Bosentan—Pruritus—Capecitabine—stomach cancer	0.000179	0.000429	CcSEcCtD
Bosentan—Leukopenia—Doxorubicin—stomach cancer	0.000179	0.000429	CcSEcCtD
Bosentan—Diarrhoea—Docetaxel—stomach cancer	0.000178	0.000429	CcSEcCtD
Bosentan—Palpitations—Doxorubicin—stomach cancer	0.000176	0.000423	CcSEcCtD
Bosentan—Anaphylactic shock—Epirubicin—stomach cancer	0.000176	0.000423	CcSEcCtD
Bosentan—Oedema—Epirubicin—stomach cancer	0.000176	0.000423	CcSEcCtD
Bosentan—Hypotension—Methotrexate—stomach cancer	0.000176	0.000422	CcSEcCtD
Bosentan—Loss of consciousness—Doxorubicin—stomach cancer	0.000175	0.000421	CcSEcCtD
Bosentan—Infection—Epirubicin—stomach cancer	0.000175	0.00042	CcSEcCtD
Bosentan—Cough—Doxorubicin—stomach cancer	0.000174	0.000418	CcSEcCtD
Bosentan—Shock—Epirubicin—stomach cancer	0.000173	0.000416	CcSEcCtD
Bosentan—Diarrhoea—Capecitabine—stomach cancer	0.000173	0.000415	CcSEcCtD
Bosentan—Nervous system disorder—Epirubicin—stomach cancer	0.000173	0.000414	CcSEcCtD
Bosentan—Dizziness—Docetaxel—stomach cancer	0.000173	0.000414	CcSEcCtD
Bosentan—Thrombocytopenia—Epirubicin—stomach cancer	0.000172	0.000414	CcSEcCtD
Bosentan—Tachycardia—Epirubicin—stomach cancer	0.000172	0.000412	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000171	0.000411	CcSEcCtD
Bosentan—Skin disorder—Epirubicin—stomach cancer	0.000171	0.00041	CcSEcCtD
Bosentan—Hyperhidrosis—Epirubicin—stomach cancer	0.00017	0.000408	CcSEcCtD
Bosentan—Insomnia—Methotrexate—stomach cancer	0.00017	0.000408	CcSEcCtD
Bosentan—Chest pain—Doxorubicin—stomach cancer	0.00017	0.000408	CcSEcCtD
Bosentan—Arthralgia—Doxorubicin—stomach cancer	0.00017	0.000408	CcSEcCtD
Bosentan—Anxiety—Doxorubicin—stomach cancer	0.000169	0.000406	CcSEcCtD
Bosentan—Paraesthesia—Methotrexate—stomach cancer	0.000169	0.000405	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000169	0.000405	CcSEcCtD
Bosentan—Discomfort—Doxorubicin—stomach cancer	0.000168	0.000403	CcSEcCtD
Bosentan—Anorexia—Epirubicin—stomach cancer	0.000168	0.000403	CcSEcCtD
Bosentan—Dyspnoea—Methotrexate—stomach cancer	0.000168	0.000403	CcSEcCtD
Bosentan—Somnolence—Methotrexate—stomach cancer	0.000167	0.000401	CcSEcCtD
Bosentan—Dizziness—Capecitabine—stomach cancer	0.000167	0.000401	CcSEcCtD
Bosentan—Dry mouth—Doxorubicin—stomach cancer	0.000166	0.000399	CcSEcCtD
Bosentan—Vomiting—Docetaxel—stomach cancer	0.000166	0.000398	CcSEcCtD
Bosentan—Dyspepsia—Methotrexate—stomach cancer	0.000166	0.000397	CcSEcCtD
Bosentan—Rash—Docetaxel—stomach cancer	0.000164	0.000395	CcSEcCtD
Bosentan—Hypotension—Epirubicin—stomach cancer	0.000164	0.000395	CcSEcCtD
Bosentan—Dermatitis—Docetaxel—stomach cancer	0.000164	0.000395	CcSEcCtD
Bosentan—Decreased appetite—Methotrexate—stomach cancer	0.000163	0.000392	CcSEcCtD
Bosentan—Headache—Docetaxel—stomach cancer	0.000163	0.000392	CcSEcCtD
Bosentan—Anaphylactic shock—Doxorubicin—stomach cancer	0.000163	0.000391	CcSEcCtD
Bosentan—Oedema—Doxorubicin—stomach cancer	0.000163	0.000391	CcSEcCtD
Bosentan—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000162	0.00039	CcSEcCtD
Bosentan—Fatigue—Methotrexate—stomach cancer	0.000162	0.000389	CcSEcCtD
Bosentan—Infection—Doxorubicin—stomach cancer	0.000162	0.000388	CcSEcCtD
Bosentan—Pain—Methotrexate—stomach cancer	0.000161	0.000386	CcSEcCtD
Bosentan—Vomiting—Capecitabine—stomach cancer	0.000161	0.000386	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.00016	0.000385	CcSEcCtD
Bosentan—Shock—Doxorubicin—stomach cancer	0.00016	0.000385	CcSEcCtD
Bosentan—Nervous system disorder—Doxorubicin—stomach cancer	0.00016	0.000383	CcSEcCtD
Bosentan—Thrombocytopenia—Doxorubicin—stomach cancer	0.000159	0.000383	CcSEcCtD
Bosentan—Rash—Capecitabine—stomach cancer	0.000159	0.000382	CcSEcCtD
Bosentan—Insomnia—Epirubicin—stomach cancer	0.000159	0.000382	CcSEcCtD
Bosentan—Dermatitis—Capecitabine—stomach cancer	0.000159	0.000382	CcSEcCtD
Bosentan—Tachycardia—Doxorubicin—stomach cancer	0.000159	0.000382	CcSEcCtD
Bosentan—Headache—Capecitabine—stomach cancer	0.000158	0.00038	CcSEcCtD
Bosentan—Skin disorder—Doxorubicin—stomach cancer	0.000158	0.00038	CcSEcCtD
Bosentan—Paraesthesia—Epirubicin—stomach cancer	0.000158	0.000379	CcSEcCtD
Bosentan—Hyperhidrosis—Doxorubicin—stomach cancer	0.000157	0.000378	CcSEcCtD
Bosentan—Dyspnoea—Epirubicin—stomach cancer	0.000157	0.000377	CcSEcCtD
Bosentan—Somnolence—Epirubicin—stomach cancer	0.000156	0.000376	CcSEcCtD
Bosentan—Anorexia—Doxorubicin—stomach cancer	0.000155	0.000373	CcSEcCtD
Bosentan—Nausea—Docetaxel—stomach cancer	0.000155	0.000372	CcSEcCtD
Bosentan—Dyspepsia—Epirubicin—stomach cancer	0.000155	0.000372	CcSEcCtD
Bosentan—Gastrointestinal pain—Methotrexate—stomach cancer	0.000154	0.000369	CcSEcCtD
Bosentan—Decreased appetite—Epirubicin—stomach cancer	0.000153	0.000367	CcSEcCtD
Bosentan—Hypotension—Doxorubicin—stomach cancer	0.000152	0.000365	CcSEcCtD
Bosentan—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000152	0.000365	CcSEcCtD
Bosentan—Fatigue—Epirubicin—stomach cancer	0.000152	0.000364	CcSEcCtD
Bosentan—Pain—Epirubicin—stomach cancer	0.00015	0.000361	CcSEcCtD
Bosentan—Constipation—Epirubicin—stomach cancer	0.00015	0.000361	CcSEcCtD
Bosentan—Nausea—Capecitabine—stomach cancer	0.00015	0.00036	CcSEcCtD
Bosentan—Urticaria—Methotrexate—stomach cancer	0.000149	0.000359	CcSEcCtD
Bosentan—Abdominal pain—Methotrexate—stomach cancer	0.000149	0.000357	CcSEcCtD
Bosentan—Body temperature increased—Methotrexate—stomach cancer	0.000149	0.000357	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000148	0.000356	CcSEcCtD
Bosentan—Insomnia—Doxorubicin—stomach cancer	0.000147	0.000354	CcSEcCtD
Bosentan—Paraesthesia—Doxorubicin—stomach cancer	0.000146	0.000351	CcSEcCtD
Bosentan—Dyspnoea—Doxorubicin—stomach cancer	0.000145	0.000349	CcSEcCtD
Bosentan—Somnolence—Doxorubicin—stomach cancer	0.000145	0.000348	CcSEcCtD
Bosentan—Gastrointestinal pain—Epirubicin—stomach cancer	0.000144	0.000345	CcSEcCtD
Bosentan—Dyspepsia—Doxorubicin—stomach cancer	0.000143	0.000344	CcSEcCtD
Bosentan—Decreased appetite—Doxorubicin—stomach cancer	0.000142	0.00034	CcSEcCtD
Bosentan—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000141	0.000338	CcSEcCtD
Bosentan—Fatigue—Doxorubicin—stomach cancer	0.00014	0.000337	CcSEcCtD
Bosentan—Urticaria—Epirubicin—stomach cancer	0.00014	0.000336	CcSEcCtD
Bosentan—Pain—Doxorubicin—stomach cancer	0.000139	0.000334	CcSEcCtD
Bosentan—Constipation—Doxorubicin—stomach cancer	0.000139	0.000334	CcSEcCtD
Bosentan—Abdominal pain—Epirubicin—stomach cancer	0.000139	0.000334	CcSEcCtD
Bosentan—Body temperature increased—Epirubicin—stomach cancer	0.000139	0.000334	CcSEcCtD
Bosentan—Hypersensitivity—Methotrexate—stomach cancer	0.000139	0.000333	CcSEcCtD
Bosentan—Asthenia—Methotrexate—stomach cancer	0.000135	0.000324	CcSEcCtD
Bosentan—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000133	0.00032	CcSEcCtD
Bosentan—Pruritus—Methotrexate—stomach cancer	0.000133	0.000319	CcSEcCtD
Bosentan—Hypersensitivity—Epirubicin—stomach cancer	0.00013	0.000311	CcSEcCtD
Bosentan—Urticaria—Doxorubicin—stomach cancer	0.000129	0.000311	CcSEcCtD
Bosentan—Abdominal pain—Doxorubicin—stomach cancer	0.000129	0.000309	CcSEcCtD
Bosentan—Body temperature increased—Doxorubicin—stomach cancer	0.000129	0.000309	CcSEcCtD
Bosentan—Diarrhoea—Methotrexate—stomach cancer	0.000129	0.000309	CcSEcCtD
Bosentan—Asthenia—Epirubicin—stomach cancer	0.000126	0.000303	CcSEcCtD
Bosentan—Pruritus—Epirubicin—stomach cancer	0.000124	0.000299	CcSEcCtD
Bosentan—Dizziness—Methotrexate—stomach cancer	0.000124	0.000299	CcSEcCtD
Bosentan—Diarrhoea—Epirubicin—stomach cancer	0.00012	0.000289	CcSEcCtD
Bosentan—Hypersensitivity—Doxorubicin—stomach cancer	0.00012	0.000288	CcSEcCtD
Bosentan—Vomiting—Methotrexate—stomach cancer	0.00012	0.000287	CcSEcCtD
Bosentan—Rash—Methotrexate—stomach cancer	0.000119	0.000285	CcSEcCtD
Bosentan—Dermatitis—Methotrexate—stomach cancer	0.000118	0.000284	CcSEcCtD
Bosentan—Headache—Methotrexate—stomach cancer	0.000118	0.000283	CcSEcCtD
Bosentan—Asthenia—Doxorubicin—stomach cancer	0.000117	0.00028	CcSEcCtD
Bosentan—Dizziness—Epirubicin—stomach cancer	0.000116	0.000279	CcSEcCtD
Bosentan—Pruritus—Doxorubicin—stomach cancer	0.000115	0.000277	CcSEcCtD
Bosentan—Vomiting—Epirubicin—stomach cancer	0.000112	0.000269	CcSEcCtD
Bosentan—Nausea—Methotrexate—stomach cancer	0.000112	0.000268	CcSEcCtD
Bosentan—Diarrhoea—Doxorubicin—stomach cancer	0.000111	0.000267	CcSEcCtD
Bosentan—Rash—Epirubicin—stomach cancer	0.000111	0.000266	CcSEcCtD
Bosentan—Dermatitis—Epirubicin—stomach cancer	0.000111	0.000266	CcSEcCtD
Bosentan—Headache—Epirubicin—stomach cancer	0.00011	0.000265	CcSEcCtD
Bosentan—Dizziness—Doxorubicin—stomach cancer	0.000108	0.000259	CcSEcCtD
Bosentan—Nausea—Epirubicin—stomach cancer	0.000105	0.000251	CcSEcCtD
Bosentan—Vomiting—Doxorubicin—stomach cancer	0.000104	0.000249	CcSEcCtD
Bosentan—Rash—Doxorubicin—stomach cancer	0.000103	0.000246	CcSEcCtD
Bosentan—Dermatitis—Doxorubicin—stomach cancer	0.000103	0.000246	CcSEcCtD
Bosentan—Headache—Doxorubicin—stomach cancer	0.000102	0.000245	CcSEcCtD
Bosentan—Nausea—Doxorubicin—stomach cancer	9.67e-05	0.000232	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—ADRB2—stomach cancer	9.65e-05	0.00055	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTT1—stomach cancer	9.5e-05	0.000542	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HSPB1—stomach cancer	9.46e-05	0.00054	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AGTR2—stomach cancer	9.46e-05	0.00054	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PPP2R1A—stomach cancer	9.45e-05	0.000539	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	9.39e-05	0.000536	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—F2R—stomach cancer	9.36e-05	0.000534	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—BMP2—stomach cancer	9.36e-05	0.000534	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKR1C3—stomach cancer	9.21e-05	0.000525	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GSTM1—stomach cancer	9.18e-05	0.000523	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALDOB—stomach cancer	9.12e-05	0.00052	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HTR1A—stomach cancer	9.11e-05	0.00052	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—GSTM1—stomach cancer	9.05e-05	0.000516	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	9.01e-05	0.000514	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—RHOA—stomach cancer	8.98e-05	0.000512	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PRKCB—stomach cancer	8.82e-05	0.000503	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ANXA1—stomach cancer	8.8e-05	0.000502	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SMAD4—stomach cancer	8.78e-05	0.000501	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCL8—stomach cancer	8.68e-05	0.000495	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.6e-05	0.000491	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ACAD8—stomach cancer	8.58e-05	0.00049	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.58e-05	0.00049	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADRB1—stomach cancer	8.52e-05	0.000486	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALOX5—stomach cancer	8.48e-05	0.000484	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	8.39e-05	0.000479	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—DPYD—stomach cancer	8.34e-05	0.000476	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FYN—stomach cancer	8.33e-05	0.000475	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RPS6—stomach cancer	8.14e-05	0.000464	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PRKCB—stomach cancer	8.01e-05	0.000457	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6ST—stomach cancer	7.98e-05	0.000455	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	7.89e-05	0.00045	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCL8—stomach cancer	7.89e-05	0.00045	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FGFR2—stomach cancer	7.82e-05	0.000446	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GMPR2—stomach cancer	7.65e-05	0.000436	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.56e-05	0.000431	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HBEGF—stomach cancer	7.48e-05	0.000427	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	7.39e-05	0.000421	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTT1—stomach cancer	7.38e-05	0.000421	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—RORA—stomach cancer	7.3e-05	0.000416	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP2A6—stomach cancer	7.29e-05	0.000416	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IRS2—stomach cancer	7.16e-05	0.000409	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6R—stomach cancer	7.12e-05	0.000406	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AKR1C3—stomach cancer	7.09e-05	0.000405	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—RHOA—stomach cancer	7.08e-05	0.000404	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—IDH3B—stomach cancer	7e-05	0.000399	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SUCLG1—stomach cancer	7e-05	0.000399	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CAV1—stomach cancer	6.95e-05	0.000396	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—APOA1—stomach cancer	6.93e-05	0.000395	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ENO1—stomach cancer	6.91e-05	0.000394	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADRB2—stomach cancer	6.9e-05	0.000394	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.8e-05	0.000388	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PPP2R1A—stomach cancer	6.77e-05	0.000386	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PRKCB—stomach cancer	6.61e-05	0.000377	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6ST—stomach cancer	6.58e-05	0.000376	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTP1—stomach cancer	6.58e-05	0.000376	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NDUFV1—stomach cancer	6.51e-05	0.000371	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NDUFS1—stomach cancer	6.51e-05	0.000371	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	6.49e-05	0.00037	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—RHOA—stomach cancer	6.43e-05	0.000367	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	6.36e-05	0.000363	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—APC—stomach cancer	6.33e-05	0.000361	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SMAD4—stomach cancer	6.28e-05	0.000358	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCL8—stomach cancer	6.22e-05	0.000355	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CD44—stomach cancer	6.13e-05	0.00035	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—MAPK3—stomach cancer	6.06e-05	0.000346	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTM1—stomach cancer	6.05e-05	0.000345	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	5.97e-05	0.00034	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FYN—stomach cancer	5.96e-05	0.00034	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.95e-05	0.000339	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6R—stomach cancer	5.87e-05	0.000335	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PGLS—stomach cancer	5.8e-05	0.000331	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—BLVRB—stomach cancer	5.8e-05	0.000331	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—MAPK1—stomach cancer	5.77e-05	0.000329	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—EGFR—stomach cancer	5.76e-05	0.000329	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ACAD8—stomach cancer	5.66e-05	0.000323	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCL8—stomach cancer	5.64e-05	0.000322	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FGFR2—stomach cancer	5.6e-05	0.000319	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPAP2A—stomach cancer	5.53e-05	0.000316	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PIK3CA—stomach cancer	5.51e-05	0.000314	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SERPINE1—stomach cancer	5.5e-05	0.000314	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—KRAS—stomach cancer	5.45e-05	0.000311	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	5.32e-05	0.000303	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—RHOA—stomach cancer	5.31e-05	0.000303	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NOS3—stomach cancer	5.25e-05	0.0003	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPP2R1A—stomach cancer	5.21e-05	0.000297	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IRS2—stomach cancer	5.13e-05	0.000292	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTP1—stomach cancer	5.11e-05	0.000292	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GMPR2—stomach cancer	5.05e-05	0.000288	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HMOX1—stomach cancer	5.04e-05	0.000288	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PIK3CA—stomach cancer	5e-05	0.000285	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CAV1—stomach cancer	4.97e-05	0.000284	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APOA1—stomach cancer	4.96e-05	0.000283	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CKB—stomach cancer	4.93e-05	0.000281	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—FBP1—stomach cancer	4.93e-05	0.000281	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NDUFA2—stomach cancer	4.93e-05	0.000281	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CA1—stomach cancer	4.93e-05	0.000281	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ERBB2—stomach cancer	4.91e-05	0.00028	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—TYMS—stomach cancer	4.75e-05	0.000271	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PRKCB—stomach cancer	4.73e-05	0.00027	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6ST—stomach cancer	4.71e-05	0.000269	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTM1—stomach cancer	4.7e-05	0.000268	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL8—stomach cancer	4.66e-05	0.000266	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLIN2—stomach cancer	4.64e-05	0.000264	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—HRAS—stomach cancer	4.63e-05	0.000264	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—IDH3B—stomach cancer	4.61e-05	0.000263	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SUCLG1—stomach cancer	4.61e-05	0.000263	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDKN1B—stomach cancer	4.55e-05	0.00026	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APC—stomach cancer	4.53e-05	0.000258	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CA2—stomach cancer	4.51e-05	0.000257	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—stomach cancer	4.43e-05	0.000253	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ERCC2—stomach cancer	4.42e-05	0.000252	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PGAM1—stomach cancer	4.39e-05	0.000251	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NT5E—stomach cancer	4.39e-05	0.000251	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCND1—stomach cancer	4.34e-05	0.000248	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—MAPK3—stomach cancer	4.34e-05	0.000247	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—JUN—stomach cancer	4.33e-05	0.000247	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NDUFV1—stomach cancer	4.29e-05	0.000245	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NDUFS1—stomach cancer	4.29e-05	0.000245	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—stomach cancer	4.21e-05	0.00024	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6R—stomach cancer	4.2e-05	0.00024	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDKN1A—stomach cancer	4.2e-05	0.00024	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALDH7A1—stomach cancer	4.19e-05	0.000239	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLCE1—stomach cancer	4.19e-05	0.000239	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—MTHFR—stomach cancer	4.15e-05	0.000237	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—MAPK1—stomach cancer	4.13e-05	0.000235	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—EGFR—stomach cancer	4.13e-05	0.000235	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAPK8—stomach cancer	4.1e-05	0.000234	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—UMPS—stomach cancer	4.02e-05	0.000229	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CA—stomach cancer	3.94e-05	0.000225	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SERPINE1—stomach cancer	3.94e-05	0.000225	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—KRAS—stomach cancer	3.9e-05	0.000222	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CAV1—stomach cancer	3.83e-05	0.000219	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PGLS—stomach cancer	3.82e-05	0.000218	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—BLVRB—stomach cancer	3.82e-05	0.000218	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOA1—stomach cancer	3.82e-05	0.000218	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RHOA—stomach cancer	3.8e-05	0.000217	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—stomach cancer	3.78e-05	0.000216	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOS3—stomach cancer	3.76e-05	0.000214	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—STAT3—stomach cancer	3.75e-05	0.000214	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PDHA1—stomach cancer	3.74e-05	0.000213	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ECHS1—stomach cancer	3.74e-05	0.000213	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.66e-05	0.000209	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPAP2A—stomach cancer	3.65e-05	0.000208	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CA—stomach cancer	3.58e-05	0.000204	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAPK3—stomach cancer	3.58e-05	0.000204	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ERBB2—stomach cancer	3.52e-05	0.000201	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—TYMP—stomach cancer	3.51e-05	0.0002	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—FADS1—stomach cancer	3.51e-05	0.0002	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MYC—stomach cancer	3.48e-05	0.000199	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAPK1—stomach cancer	3.41e-05	0.000194	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EGFR—stomach cancer	3.41e-05	0.000194	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARG—stomach cancer	3.37e-05	0.000192	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL8—stomach cancer	3.33e-05	0.00019	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—HRAS—stomach cancer	3.31e-05	0.000189	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SREBF2—stomach cancer	3.29e-05	0.000188	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDKN1B—stomach cancer	3.26e-05	0.000186	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—FBP1—stomach cancer	3.25e-05	0.000185	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NDUFA2—stomach cancer	3.25e-05	0.000185	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CKB—stomach cancer	3.25e-05	0.000185	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CA1—stomach cancer	3.25e-05	0.000185	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—RORA—stomach cancer	3.25e-05	0.000185	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—KRAS—stomach cancer	3.22e-05	0.000184	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—stomach cancer	3.17e-05	0.000181	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCND1—stomach cancer	3.11e-05	0.000177	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—JUN—stomach cancer	3.1e-05	0.000177	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLIN2—stomach cancer	3.06e-05	0.000174	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALDOB—stomach cancer	3.05e-05	0.000174	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—stomach cancer	3.03e-05	0.000173	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—stomach cancer	3.02e-05	0.000172	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDKN1A—stomach cancer	3.01e-05	0.000171	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CA2—stomach cancer	2.97e-05	0.00017	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CA—stomach cancer	2.96e-05	0.000169	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAPK8—stomach cancer	2.93e-05	0.000167	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PGAM1—stomach cancer	2.9e-05	0.000165	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NT5E—stomach cancer	2.9e-05	0.000165	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NOS3—stomach cancer	2.9e-05	0.000165	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.87e-05	0.000164	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.87e-05	0.000163	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TP53—stomach cancer	2.86e-05	0.000163	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALOX5—stomach cancer	2.83e-05	0.000162	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—DPYD—stomach cancer	2.79e-05	0.000159	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLCE1—stomach cancer	2.76e-05	0.000158	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.76e-05	0.000158	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HRAS—stomach cancer	2.73e-05	0.000156	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—stomach cancer	2.71e-05	0.000154	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—STAT3—stomach cancer	2.68e-05	0.000153	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—UMPS—stomach cancer	2.65e-05	0.000151	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS2—stomach cancer	2.65e-05	0.000151	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—stomach cancer	2.62e-05	0.000149	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAPK3—stomach cancer	2.56e-05	0.000146	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.52e-05	0.000144	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MYC—stomach cancer	2.49e-05	0.000142	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PDHA1—stomach cancer	2.46e-05	0.000141	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ECHS1—stomach cancer	2.46e-05	0.000141	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTT1—stomach cancer	2.46e-05	0.000141	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAPK1—stomach cancer	2.44e-05	0.000139	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EGFR—stomach cancer	2.44e-05	0.000139	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2A6—stomach cancer	2.43e-05	0.000139	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKR1C3—stomach cancer	2.37e-05	0.000135	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—TYMP—stomach cancer	2.32e-05	0.000132	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—FADS1—stomach cancer	2.32e-05	0.000132	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ENO1—stomach cancer	2.31e-05	0.000132	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KRAS—stomach cancer	2.3e-05	0.000131	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.27e-05	0.00013	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SREBF2—stomach cancer	2.17e-05	0.000124	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—RORA—stomach cancer	2.14e-05	0.000122	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CA—stomach cancer	2.12e-05	0.000121	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CD44—stomach cancer	2.05e-05	0.000117	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TP53—stomach cancer	2.05e-05	0.000117	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALDOB—stomach cancer	2.01e-05	0.000115	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.99e-05	0.000113	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HRAS—stomach cancer	1.96e-05	0.000112	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—stomach cancer	1.87e-05	0.000107	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALOX5—stomach cancer	1.87e-05	0.000107	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—DPYD—stomach cancer	1.84e-05	0.000105	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPP2R1A—stomach cancer	1.74e-05	9.93e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTP1—stomach cancer	1.71e-05	9.74e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HMOX1—stomach cancer	1.68e-05	9.61e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CA—stomach cancer	1.63e-05	9.3e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTT1—stomach cancer	1.62e-05	9.27e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.61e-05	9.16e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—TYMS—stomach cancer	1.59e-05	9.06e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTM1—stomach cancer	1.57e-05	8.95e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.56e-05	8.91e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ENO1—stomach cancer	1.52e-05	8.68e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ERCC2—stomach cancer	1.48e-05	8.42e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MTHFR—stomach cancer	1.39e-05	7.91e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CD44—stomach cancer	1.35e-05	7.7e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CAV1—stomach cancer	1.28e-05	7.3e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOA1—stomach cancer	1.28e-05	7.28e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.22e-05	6.97e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.15e-05	6.55e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTP1—stomach cancer	1.13e-05	6.42e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARG—stomach cancer	1.12e-05	6.41e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMOX1—stomach cancer	1.11e-05	6.34e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—TYMS—stomach cancer	1.05e-05	5.97e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTM1—stomach cancer	1.03e-05	5.9e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—stomach cancer	1.01e-05	5.77e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ERCC2—stomach cancer	9.73e-06	5.55e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NOS3—stomach cancer	9.67e-06	5.52e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MTHFR—stomach cancer	9.15e-06	5.22e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS2—stomach cancer	8.85e-06	5.05e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CAV1—stomach cancer	8.44e-06	4.81e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOA1—stomach cancer	8.42e-06	4.8e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARG—stomach cancer	7.42e-06	4.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—stomach cancer	6.67e-06	3.8e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NOS3—stomach cancer	6.38e-06	3.64e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS2—stomach cancer	5.83e-06	3.33e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CA—stomach cancer	5.44e-06	3.1e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.59e-06	2.05e-05	CbGpPWpGaD
